Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Lymphoma 13Hodgkin Disease 12Teratoma 6Testicular Neoplasms 4Endodermal Sinus Tumor 4Carcinoma, Embryonal 3Testicular Germ Cell Tumor 2Seminoma 2Ovarian Germ Cell Cancer 2Neoplasm Metastasis 2Cardiotoxicity 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Teratoma, Testicular 1Sertoli-Leydig Cell Tumor 1Pleural Effusion, Malignant 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Mediastinal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1HIV Infections 1Granulosa cell tumor of the ovary 1

Interventions

Amifostine 4Cisplatin 3Radiotherapy 2Paclitaxel 2Filgrastim 2Carboplatin 2Peripheral Blood Stem Cell Transplantation 1Octreotide 1Melphalan 1Furosemide 1Etoposide 1Erythropoietin 1Epoetin Alfa 1Duloxetine Hydrochloride 1Brachytherapy 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Drug-Related Side Effects and Adverse Reactions × Bleomycin × Clear all
NCT00003811 2013-07-04

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
27 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡